Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus

scientific article published on September 2012

Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ACR.21691
P932PMC publication ID3705733
P698PubMed publication ID22549897
P5875ResearchGate publication ID224879069

P50authorPatricia P KatzQ91750245
Edward YelinQ91988470
Lindsey A. CriswellQ67485118
Jinoos YazdanyQ88617667
Laura TrupinQ88617670
P2093author name stringSara G Murray
Laura J Julian
Rachel Kaiser
P2860cites workThe CES-D Scale: A Self-Report Depression Scale for Research in the General PopulationQ26778378
Predictors of cognitive dysfunction in patients with systemic lupus erythematosusQ28213684
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosusQ29614922
Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilitiesQ33731244
Work dynamics among persons with systemic lupus erythematosusQ33871651
Impact of memory impairment on employment status in persons with systemic lupus erythematosusQ33871723
Validity of self-reported stroke in elderly African Americans, Caribbean Hispanics, and WhitesQ33897009
Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health studyQ34017775
The prevalence of neuropsychiatric syndromes in systemic lupus erythematosusQ34335863
A review of the sapporo and revised Sapporo criteria for the classification of antiphospholipid syndrome. Where do the revised sapporo criteria add value?Q36841752
Validity of brief screening tools for cognitive impairment in rheumatoid arthritis and systemic lupus erythematosusQ36995068
Cardiovascular and disease-related predictors of depression in systemic lupus erythematosusQ37019825
Using the Center for Epidemiologic Studies Depression Scale to screen for depression in systemic lupus erythematosusQ37036848
Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohortQ37137321
Cognitive impairment: an increasingly important complication of type 2 diabetes: the age, gene/environment susceptibility--Reykjavik studyQ37306134
History of coronary heart disease and cognitive performance in midlife: the Whitehall II studyQ37339994
Norms for letter and category fluency: demographic corrections for age, education, and ethnicityQ38449676
Cognitive impairment after stroke: clinical determinants and its associations with long-term stroke outcomesQ40643537
Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosusQ41608189
Cognitive dysfunction in systemic lupus erythematosus: prevalence and correlatesQ43425230
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study.Q43626449
Effects of age and hypertension status on cognition: the Veterans Affairs Normative Aging StudyQ45332910
Benton Controlled Oral Word Association Test: reliability and updated norms.Q45941429
Hypertension and the brain: vulnerability of the prefrontal regions and executive functionsQ48116852
Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemic stroke and stroke severity in systemic lupus erythematosusQ48312290
Ambulatory blood pressure as an independent determinant of brain atrophy and cognitive function in elderly hypertensionQ48429368
"Subcortical" cognitive impairment in patients with systemic lupus erythematosus.Q49049719
Validity of self-reported hypertension in the National Health and Nutrition Examination Survey III, 1988-1991.Q50625463
Validation of a systemic lupus activity questionnaire (SLAQ) for population studiesQ50765174
Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations.Q51069301
Acute variation in cognitive function in hemodialysis patients: a cohort study with repeated measures.Q51973262
The clinical utility of the Hopkins Verbal Learning Test as a screening test for mild dementia.Q52169153
General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosusQ57753752
Cardiovascular risk factors and cognitive decline in middle-aged adultsQ60692491
Cognitive impairment in patients with systemic lupus erythematosusQ68136504
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham StudyQ73106702
A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosusQ77352546
P433issue9
P921main subjectsystemic lupus erythematosusQ1485
cardiovascular diseaseQ389735
cognitive dysfunctionQ57859955
P304page(s)1328-1333
P577publication date2012-09-01
P1433published inArthritis Care and ResearchQ15754720
P1476titleCardiovascular disease and cognitive dysfunction in systemic lupus erythematosus
P478volume64

Reverse relations

cites work (P2860)
Q51120688A nationwide study of SLE in Japanese identified subgroups of patients with clear signs patterns and associations between signs and age or sex.
Q64099017Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus
Q39644309Anti-NR2 antibodies, blood-brain barrier, and cognitive dysfunction
Q27016554Cardiovascular disease in lupus: insights and updates
Q54968810Disease activity, autoantibodies, and inflammatory molecules in serum and cerebrospinal fluid of patients with Systemic Lupus Erythematosus and Cognitive Dysfunction.
Q92800609Efficacy of Acceptance and Commitment Therapy in Reducing Disappointment, Psychological Distress, and Psychasthenia among Systemic Lupus Erythematosus (SLE) Patients
Q28070338Multimorbidity in rheumatic conditions
Q38247180Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers
Q41128018Non-criteria anti-phospholipid antibodies and cognitive impairment in SLE.
Q38255794Noradrenaline transmission reducing drugs may protect against a broad range of diseases
Q55514340The association between systemic lupus erythematosus and dementia A meta-analysis.
Q28072610The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus

Search more.